A new study in the journal Diabetes Technology & Therapeutics evaluated the effects of a regimen of inhaled technosphere ...
Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the effects of a regimen of inhaled technosphere insulin (TI) and insulin degludec over 30 weeks and its ...
A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...
In 2015, the FDA finally approved Tresiba (insulin degludec) and Ryzodeg (insulin aspart and insulin degludec) on the basis of an interim analysis from DEVOTE. The primary endpoint of the DEVOTE ...
Justice Martin Burns told the court that Brendan was a "dangerous, highly manipulative" man who allegedly convinced Jason to deny his daughter insulin. Burns said he believed that if the group ...
Insulin is a hormone that allows glucose in the blood to enter cells, providing them with the energy to function. A lack of adequate insulin plays a key role in the development of diabetes ...
The various makes and models of pump available use different technological solutions for delivering insulin. To obtain marketing approval, manufacturing companies must submit a premarket ...
The company said it has decided to stop distributing its once-daily basal insulin Tresiba (insulin degludec) in Germany - Europe's largest pharmaceutical market - in the wake of a "negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results